Show simple item record

dc.contributor.authorParker, C
dc.date.accessioned2018-01-24T15:06:48Z
dc.date.issued2018-02
dc.identifier.citationEuropean urology, 2018, 73 (2), pp. 304 - ?
dc.identifier.issn0302-2838
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/1022
dc.identifier.eissn1873-7560
dc.identifier.doi10.1016/j.eururo.2017.11.007
dc.formatPrint-Electronic
dc.format.extent304 - ?
dc.languageeng
dc.language.isoeng
dc.rights.urihttps://www.rioxx.net/licenses/under-embargo-all-rights-reserved
dc.subjectHumans
dc.subjectBone Neoplasms
dc.subjectDiphosphonates
dc.subjectImidazoles
dc.subjectBone Density Conservation Agents
dc.titleRe: Effect of Longer-interval Versus Standard Dosing of Zoledronic Acid on Skeletal Events in Patients with Bone Metastases.
dc.typeJournal Article
dcterms.dateAccepted2017-11-09
rioxxterms.versionofrecord10.1016/j.eururo.2017.11.007
rioxxterms.licenseref.urihttps://www.rioxx.net/licenses/under-embargo-all-rights-reserved
rioxxterms.licenseref.startdate2018-02
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfEuropean urology
pubs.issue2
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.publication-statusPublished
pubs.volume73
pubs.embargo.termsNot known
dc.contributor.icrauthorParker, Chrisen
dc.contributor.icrauthorMarsden,en


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record